[The development and a clinical trial of an erythrocytic diagnostic agent for determining antibodies to the liver-specific lipoprotein].
A simple method for the preparation of purified liver-specific protein has been developed and a sensitive and specific test-system has been created on its basis for the detection of antiLSP. The titres of antiLSP correlate with the activity of the pathological processes in patients with acute and chronic hepatitides. Immunosuppressive therapy results in elimination of antiLSP.